---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-012004"
form_type: "8-K"
ticker: "DCTH"
cik: "0000872912"
company_name: "DELCATH SYSTEMS, INC."
filed_at: "2026-02-26T23:59:59+00:00"
generated_at: "2026-05-15T23:58:33.056513+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Delcath reports FY2025 revenue $85.2M, net income $2.7M; guides FY2026 revenue ≥$100M

## Summary
- FY2025 total revenue $85.2M, up 129% YoY ($37.2M); HEPZATO revenue $78.8M, CHEMOSAT $6.4M.
- Full-year net income $2.7M vs net loss $26.4M in 2024; adjusted EBITDA $25.1M.
- Cash $91.0M, no debt; repurchased 628,572 shares for $6.0M.
- FY2026 guidance: total revenue at least $100M, HEPZATO volume growth ≥20%, gross margin 84-87%.
- 28 active centers; 140% procedure volume growth in 2025; publications including CHOPIN study.

## SEC filing metadata
- accession: 0001628280-26-012004
- form_type: 8-K
- ticker: DCTH
- cik: 0000872912
- company_name: DELCATH SYSTEMS, INC.
- filed_at: 2026-02-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/872912/000162828026012004/0001628280-26-012004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/872912/000162828026012004/dcth-20260226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-012004
- JSON: https://secwatch.observer/filing/0001628280-26-012004.json
- Plain text: https://secwatch.observer/filing/0001628280-26-012004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.